Salerno Pharmaceuticals, LP — Form D
Salerno Pharmaceuticals, LP of NEWPORT BEACH, CA, a company, filed a Form D exempt-offering notice with the SEC on 2017-01-13. The offering totals $5.0M, of which $3.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2017-01-13
- Form: D
- Accession: 0001694399-17-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $3.0M
- Remaining: $2.0M
- Investors: 19
- Date of first sale: 2016-12-30
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-278478
Issuer
- Name: Salerno Pharmaceuticals, LP
- CIK: 0001694399
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 610 NEWPORT CENTER DRIVE, NEWPORT BEACH, CA, 92660
- Phone: 949-706-3600
Officers, directors & promoters (2)
| Name | Role | Location |
|---|
| Edward W McKenna | Executive Officer | Newport Beach, CA |
| Thomas W Courtney, Jr. | Executive Officer | Newport Beach, CA |
Other filings by this issuer (2)
More